General information about company
Scrip code	539997
NSE Symbol
MSEI Symbol
ISIN	INE552U01010
Name of the entity	KWALITY PHARMACEUTICALS LIMITED
Date of start of financial year	01-04-2023
Date of end of financial year	31-03-2024
Reporting Quarter	Yearly
Date of Report	31-03-2024
Risk management committee	Not Applicable
Market Capitalisation as per immediate previous Financial Year	Top 2000 listed entities

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

Textual Information(1)

Whether the listed entity has a Regular Chairperson

No

Whether Chairperson is related to MD or CEO

No

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of Birth

1

Mr

RAMESH ARORA

ACYPA9927E

00462656

Executive Director

Not Applicable

MD

12-06-1954

2

Mr

AJAY KUMAR ARORA

AAUPA6280C

00462664

Executive Director

Not Applicable

29-01-1968

3

Mr

ADITYA ARORA

BCPPA0239K

07320410

Executive Director

Not Applicable

17-02-1994

4

Mrs

GEETA ARORA

AAMPA8923C

03155615

Executive Director

Not Applicable

29-11-1970

5

Mrs

ANJU ARORA

AAMPA8922D

03155641

Executive Director

Not Applicable

01-02-1962

6

Mr

PANKAJ TAKKAR

ACYPT7650H

07414345

Non-Executive - Independent Director

Not Applicable

17-08-1977

7

Mr

KIRAN KUMAR VERMA

ABXPV3971B

07415375

Non-Executive - Independent Director

Not Applicable

02-12-1972

8

Mr

RAVI SHANKER SINGH

AIPPS4271G

02303588

Non-Executive - Independent Director

Not Applicable

21-05-1973

9

Mr

KARTIK KAPUR

DACPK4875E

08966816

Non-Executive - Independent Director

Not Applicable

18-04-1994

10

Mr

PRASHANTH VELLANKI

AHJPV9319F

05182633

Non-Executive - Independent Director

Not Applicable

23-01-1989

I. Composition of Board of Directors

Disqualification of Directors under section 164 of the Companies Act, 2013

SrWhether the director is disqualified?Start Date of disqualificationEnd Date of disqualificationDetails of disqualificationCurrent status

1

No

Active

2

No

Active

3

No

Active

4

No

Active

5

No

Active

6

No

Active

7

No

Active

8

No

Active

9

No

Active

10

No

Active

I. Composition of Board of Directors
Sr		Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]		Date of passing special resolution		Initial Date of appointment		Date of Re-appointment		Date of cessation		Tenure of director (in months)		No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)		No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)]		Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)		No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)		Reason for Cessation		Notes for not providing PAN		Notes for not providing DIN
1		NA				04-05-1983		16-01-2021				38		1		0		0		0
2		NA				01-08-1995		16-01-2021				38		1		0		0		0
3		NA				22-10-2015		30-09-2021				30		1		0		1		0
4		NA				01-10-2010		16-01-2021				38		1		0		1		0
5		NA				01-10-2010		16-01-2021				38		1		0		1		0
6		NA				01-02-2016		01-02-2021				38		1		1		1		1
7		NA				01-02-2016		01-02-2021				38		1		1		1		0
8		NA				01-02-2016		01-02-2021				38		1		1		1		1
9		NA				16-01-2021						38		1		1		0		0
10		NA				16-03-2023						12		1		1		0		0

Text Block

Textual Information(1)

The Composition of Board of Directors of our company is as follows:

Executive Directors - 5

Non- Executive (Independent) Directors - 5

-----

Total Directors 10

------

As per Regulation 17 (1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 there is optimium combination of executive and non-executive directors and fifty percent of board of directors comprise of non-executive Directors.

As per of Regulation 17(1)(b) , the Company doesnot have regular (executive/non-executive) Chairperson, therefore half of the board of directors of the company are Independent Directors.

Audit Committee Details
Whether the Audit Committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	07414345	PANKAJ TAKKAR	Non-Executive - Independent Director	Chairperson	14-03-2016
2	07320410	ADITYA ARORA	Executive Director	Member	14-03-2016
3	07415375	KIRAN KUMAR VERMA	Non-Executive - Independent Director	Member	14-03-2016

Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	07415375	KIRAN KUMAR VERMA	Non-Executive - Independent Director	Chairperson	14-03-2016
2	07414345	PANKAJ TAKKAR	Non-Executive - Independent Director	Member	14-03-2016
3	02303588	RAVI SHANKER SINGH	Non-Executive - Independent Director	Member	14-03-2016

Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	02303588	RAVI SHANKER SINGH	Non-Executive - Independent Director	Chairperson	14-03-2016
2	03155615	GEETA ARORA	Executive Director	Member	14-03-2016
3	03155641	ANJU ARORA	Executive Director	Member	14-03-2016

Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks

Corporate Social Responsibility Committee
Whether the Corporate Social Responsibility Committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	03155615	GEETA ARORA	Executive Director	Chairperson	03-04-2017
2	07320410	ADITYA ARORA	Executive Director	Member	03-04-2017
3	07414345	PANKAJ TAKKAR	Non-Executive - Independent Director	Member	03-04-2017

Other Committee
Sr	DIN Number	Name of Committee members	Name of other committee	Category 1 of directors	Category 2 of directors	Remarks

Annexure 1
Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr	Date(s) of meeting (if any) in the previous quarter	Date(s) of meeting (if any) in the current quarter	Maximum gap between any two consecutive (in number of days)	Notes for not providing Date	Whether requirement of Quorum met (Yes/No)	Total Number of Directors as on date of the meeting	Number of Directors present* (All directors including Independent Director)	No. of Independent Directors attending the meeting*
1	04-11-2023				Yes	10	7	2
2	22-11-2023		17		Yes	10	7	2
3	14-12-2023		21		Yes	10	7	2
4		25-01-2024	41		Yes	10	6	1
5		06-02-2024	11		Yes	10	7	2
6		29-03-2024	51		Yes	10	8	3

Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr	Name of Committee	Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)	Maximum gap between any two consecutive (in number of days)	Name of other committee	Reson for not providing date	Whether requirement of Quorum met (Yes/No)	Total Number of Directors in the Committee as on date of the meeting	Number of Directors Present (All Directors including Independent Director)	No. of Independent Directors attending the meeting*	No. of members attending the meeting (other than Board of Directors)
1	Audit Committee	04-11-2023				Yes	3	3	2	0
2	Audit Committee	06-02-2024	93			Yes	3	3	2	0
3	Stakeholders Relationship Committee	17-10-2023				Yes	3	3	1	0
4	Stakeholders Relationship Committee	17-01-2024	91			Yes	3	3	1	0
5	Nomination and remuneration committee	18-03-2024	60			Yes	3	3	3	0
6	Corporate Social Responsibility Committee	29-03-2024				Yes	3	3	1	0

Annexure 1
V. Related Party Transactions
Sr	Subject	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
1	Whether prior approval of audit committee obtained	Yes
2	Whether shareholder approval obtained for material RPT	NA
3	Whether details of RPT entered into pursuant to omnibus approval have been reviewed by Audit Committee	Yes

Annexure 1
VI. Affirmations
Sr	Subject	Compliance status (Yes/No)
1	The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015	Yes
2	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee	Yes
3	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee	Yes
4	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee	Yes
5	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities)	NA
6	The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
7	The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
8	This report and/or the report submitted in the previous quarter has been placed before Board of Directors.	Yes

Annexure 1
Sr	Subject	Compliance status
1	Name of signatory	Gurpreet Kaur
2	Designation	Company Secretary and Compliance Officer

Annexure II
Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of Listing Regulations
Sr	Item	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.	Web address
1	Details of business	Yes		www.kwalitypharma.com
2	Terms and conditions of appointment of independent directors	Yes		www.kwalitypharma.com
3	Composition of various committees of board of directors	Yes		www.kwalitypharma.com
4	Code of conduct of board of directors and senior management personnel	Yes		www.kwalitypharma.com
5	Details of establishment of vigil mechanism/ Whistle Blower policy	Yes		www.kwalitypharma.com
6	Criteria of making payments to non-executive directors	Yes		www.kwalitypharma.com
7	Policy on dealing with related party transactions	Yes		www.kwalitypharma.com
8	Policy for determining �material� subsidiaries	Yes		www.kwalitypharma.com
9	Details of familiarization programmes imparted to independent directors	Yes		www.kwalitypharma.com
10	Email address for grievance redressal and other relevant details	Yes		www.kwalitypharma.com
11	Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances	Yes		www.kwalitypharma.com
12	Financial results	Yes		www.kwalitypharma.com
13	Shareholding pattern	Yes		www.kwalitypharma.com
14	Details of agreements entered into with the media companies and/or their associates	NA

Annexure II
Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of Listing Regulations
Sr	Item	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.	Web address
15.1	Schedule of analyst or institutional investor meet and presentations made by the listed entity to analysts or institutional investors simultaneously with submission to stock exchange	NA
15.2	Audio or video recordings and transcripts of post earnings/quarterly calls	NA
16	New name and the old name of the listed entity	NA
17	Advertisements as per regulation 47 (1)	Yes		www.kwalitypharma.com
18	Credit rating or revision in credit rating obtained	Yes		www.kwalitypharma.com
19	Separate audited financial statements of each subsidiary of the listed entity in respect of a relevant financial year	Yes		www.kwalitypharma.com
20	Secretarial Compliance Report	Yes		www.kwalitypharma.com
21	Materiality Policy as per Regulation 30 (4)	Yes		www.kwalitypharma.com
22	Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5)	Yes		www.kwalitypharma.com
23	Disclosures under regulation 30(8)	NA
24	Statements of deviation(s) or variations(s) as specified in regulation 32	NA
25	Dividend Distribution policy as per Regulation 43A(1)	NA
26	Annual return as provided under section 92 of the Companies Act, 2013	Yes		www.kwalitypharma.com
27	Confirmation that the above disclosures are in a separate section as specified in regulation 46(2)	Yes		www.kwalitypharma.com
28	Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updating	Yes		www.kwalitypharma.com

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
1	Independent director(s) have been appointed in terms of specified criteria of �independence� and/or �eligibility�	16(1)(b) & 25(6)	Yes
2	Board composition	17(1), 17(1A) & 17(1C), 17(1D) & 17(1E)	Yes
3	Meeting of Board of directors	17(2)	Yes
4	Quorum of Board meeting	17(2A)	Yes
5	Review of Compliance Reports	17(3)	Yes
6	Plans for orderly succession for appointments	17(4)	Yes
7	Code of Conduct	17(5)	Yes
8	Fees/compensation	17(6)	Yes
9	Minimum Information	17(7)	Yes
10	Compliance Certificate	17(8)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
11	Risk Assessment & Management	17(9)	Yes
12	Performance Evaluation of Independent Directors	17(10)	Yes
13	Recommendation of Board	17(11)	Yes
14	Maximum number of Directorships	17A	Yes
15	Composition of Audit Committee	18(1)	Yes
16	Meeting of Audit Committee	18(2)	Yes
17	Role of Audit Committee and information to be reviewed by the audit committee	18(3)	Yes
18	Composition of nomination & remuneration committee	19(1) & (2)	Yes
19	Quorum of Nomination and Remuneration Committee meeting	19(2A)	Yes
20	Meeting of Nomination and Remuneration Committee	19(3A)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
21	Role of Nomination and Remuneration Committee	19(4)	Yes
22	Composition of Stakeholder Relationship Committee	20(1), 20(2) & 20(2A)	Yes
23	Meeting of Stakeholders Relationship Committee	20(3A)	Yes
24	Role of Stakeholders Relationship Committee	20(4)	Yes
25	Composition and role of risk management committee	21(1),(2),(3),(4)	NA
26	Meeting of Risk Management Committee	21(3A)	NA
27	Quorum of Risk Management Committee meeting	21(3B)	NA
28	Gap between the meetings of the Risk Management Committee	21(3C)	NA
29	Vigil Mechanism	22	Yes
30	Policy for related party Transaction	23(1), (1A), (5), (6), & (8)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
31	Prior or Omnibus approval of Audit Committee for all related party transactions	23(2), (3)	Yes
32	Approval for material related party transactions	23(4)	NA
33	Disclosure of related party transactions on consolidated basis	23(9)	Yes
34	Composition of Board of Directors of unlisted material Subsidiary	24(1)	NA
35	Other Corporate Governance requirements with respect to subsidiary of listed entity	24(2),(3),(4),(5) & (6)	NA
36	Alternate Director to Independent Director	25(1)	NA
37	Maximum Tenure	25(2)	Yes
38	Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism	25(2A)	Yes
39	Meeting of independent directors	25(3) & (4)	Yes
40	Familiarization of independent directors	25(7)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is �No� details of non-compliance may be given here.
41	Declaration from Independent Director	25(8) & (9)	Yes
42	Directors and Officers insurance	25(10)	NA
43	Confirmation with respect to appointment of Independent Directors who resigned from the listed entity	25(11)	Yes
44	Memberships in Committees	26(1)	Yes
45	Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel	26(3)	Yes
46	Disclosure of Shareholding by Non-Executive Directors	26(4)	Yes
47	Policy with respect to Obligations of directors and senior management	26(2) & 26(5)	Yes
48	Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity	26(6)	Yes
49	Vacancies in respect Key Managerial Personnel	26A(1) & 26A(2)	Yes
	Any other information to be provided - Add Notes

Annexure II
1	Name of signatory	GURPREET KAUR
2	Designation	Company Secretary and Compliance Officer

Annexure II
III. Affirmations
Sr	Particulars	Compliance status (Yes/No/NA)
1	The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied	Yes
	Any other information to be provided

Annexure II
1	Name of signatory	GURPREET KAUR
2	Designation	Company Secretary and Compliance Officer

Additional Half yearly Disclosure
Applicability of disclosure		Not Applicable
Reason for Non Applicability		Textual Information(1)

Text Block
Textual Information(1)	The Company has not advanced any loan/guarantee/any security to any promoter/promoter group/ directors (including relative) or any other entity cantrolled by them and to KMPs or any other entity controlled by them.

Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter		No
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr.	Date of the event	Brief details of the event

Signatory Details
Name of signatory	GURPREET KAUR
Designation of person	Company Secretary and Compliance Officer
Place	AMRITSAR
Date	20-04-2024